BMC Infectious Diseases

, 16:496 | Cite as

Vancomycin in infusion during vitrectomy in surgical treatment of acute postoperative and posttraumatic endophthalmitis

  • Robert Rejdak
  • Tomasz Choragiewicz
  • Agnieszka Kalinowska
  • Michael J. Koss
  • Piotr Ksiazek
  • Joanna Moneta-Wielgos
  • Ryszard Maciejewski
  • Anselm G. Jünemann
  • Katarzyna Nowomiejska
Open Access
Research article
Part of the following topical collections:
  1. Bacterial and fungal diseases

Abstract

Background

Endophthalmitis is potentially devastating intraocular inflammation following eye trauma or surgery. We describe the visual outcomes and causative pathogens in acute bacterial postoperative and posttraumatic endophthalmitis treated with immediate pars plana vitrectomy (PPV) with Vancomycin dissolved in the infusion fluid.

Methods

Clinical records of consecutive 30 patients with postoperative endophthalmitis and 15 patients with posttraumatic endophthalmitis were evaluated. Vancomycin was administered constantly in the infusion fluid at the time of complete PPV. Cultures were prepared from anterior chamber paracentesis. The mean follow-up period was 13 months.

Results

The visual acuities were improved in 38 cases (84 %) and remained stable in seven cases (16 %). Median post-PPV visual acuity was 1.0 logMAR in a group with postoperative endophthalmitis and 1.3 logMAR in a group with posttraumatic endophthalmitis (p < 0.05). Twenty cases (44 %) were culture-positive (Staphylococcus, Streptococcus, Enterococcus and Bacillus spp).

Conclusions

Early PPV with Vanomycin in infusion leads to vision improvement in patients with both posttraumatic and postoperative endophthalmitis. In our series of 45 cases culture was positive only in half of the cases.

Keywords

Endophthalmitis Ocular trauma Vitrectomy 

Background

Endophthalmitis is a severe and potentially devastating intraocular purulent inflammation resulting from infectious agent invasion to the posterior segment of the eye occurring as a complication of an operation procedure, penetrating eye injuries or hematogenous spread of bacteria [1]. Endophthalmitis may lead to loss of vision due to irreversible damage of photoreceptors caused by bacterial toxins.

Approximately 70 % of cases occur as a complication of the intraocular surgery, mostly cataract extraction. Capsular or zonular surgical complication and wound leak on the next day after surgery are the main risk factors for the postoperative endophthalmitis [2]. Posttraumatic endophthalmitis following open-globe injuries accounts for one-fourth of all cases of endophthalmitis [3] and may have a significant impact on socioeconomic life. The likelihood of infection after penetrating ocular trauma (3.3 to 17 %) is 100 times greater than after cataract surgery (0.05 %) [4]. Rural setting [5], delayed wound closure [6] and dirty wound [7] are the main risk factors for endophthalmitis after penetrating eye trauma. Other risk factors are: retained intraocular foreign body (IOFB) [6] and ruptured lens capsule [4].

The treatment of endophthalmitis has evolved during the last several decades. Before the age of vitreoretinal surgery, enucleation of affected eye was usually performed [8]. In the 1970s treatment of endophthalmitis greatly improved by introduction of intravitreal antibiotics. Intravitreal injection of empirical choice antibiotic (1 mg Vancomycin or 2.25 mg Ceftizidime) is still used in many countries in the primary treatment of endophthalmitis and is called the “silver standard” by European Society of Cataract and Refractive Surgeons (ESCRS) guidelines [2]. Since 1980, the success rate of surgical treatment-pars plana vitrectomy (PPV)–defined as final vision of 20/400 or better–has increasingly improved, ranging from 42 to 73 %. Therefore, complete PPV is now considered the “gold standard” in the treatment of endophthalmitis [2].

Vancomycin is considered to be the drug of choice for empiric coverage of Gram-positive organisms – the most common cause both in posttraumatic and postoperative endophthalmitis. Vancomycin is widely used in the treatment of endophthalmitis as intravitreal injection alone or at the end of PPV using the 25G or 30G needle [2].

The objective of this study was to characterize the visual outcome and causative pathogens in patients with postoperative and posttraumatic endophthalmitis who had been treated with immediate PPV with Vancomycin dissolved in infusion.

Methods

In this noncomparative case series we have analyzed retrospectively medical records of consecutive 45 patients with acute endophthalmitis - 15 posttraumatic and 30 acute postoperative bacterial endophthalmitis treated at the Department of General Ophthalmology in Lublin, Poland, between 2010 and 2015. This study followed the tenets of the Declaration of Helsinki. The treatment chosen in the study was a part of a standard care. The study was approved by the local Ethic Committee at the University in Lublin, Poland. The patients gave their written informed consent to participate in the study and publish the data.

Inclusion criteria were as follows: (1) clinical signs of endophthalmitis: lid edema, chemosis, conjunctival hyperaemia, anterior chamber and vitreous cells, hypopyon, corneal edema, corneal ring infiltrate, reduced red reflex and afferent pupillary defect; (2) eye trauma or intraocular surgery performed less than 6 weeks ago; (3) PPV with Vancomycin in tapping performed within 6 h from the beginning of signs of endophthalmitis.

The diagnosis of endophthalmitis was made on the basis of clinical examination and ultrasonography. The patient data were recorded including: age, gender, type of trauma, previous surgical procedures, primary and final visual acuity, result of microbiological examination. Functional (best-corrected visual acuity: improved, stable, worsened) and anatomic outcomes (retinal attachment, intraocular pressure) were assessed during the follow-up.

Snellen decimal best corrected visual acuity was recorded in the affected eyes and converted into logarithm of the minimum angle of resolution (logMAR). Initial and the final best-corrected visual acuities were compared.

There were 13 men and two women in posttraumatic group and 14 men and 16 women in postoperative group. Overall, the median age of patients was 60 years (range 20–80 years), 40 years in posttraumatic patients and 70 years in postoperative patients (p < 0.0001).

Previous surgical procedures included: 20 phacoemulsyfications with IOL implantation, three bevacizumab injections, three secondary IOL implantations, one trabeculectomy, one Ahmed valve implantation, one PPV, one extracapsular cataract extraction.

Most of the surgeries included cataract surgery. As all cataract surgeries were performed in another hospitals, we do not have a knowledge what was the incision length, if preoperative fluorochinolones and intracameral cefuroxime was used as a prophylaxis of endophthalmitis.

Ocular trauma data included the mechanism and type of injury classified according to the Ocular Trauma Classification. Zone I injuries are confined to the cornea, zone II injuries involve the anterior 5 mm of the sclera, and zone III injuries involved full-thickness scleral defects more posterior than 5 mm from the limbus [9]. Wound location in posttraumatic eyes was classified as zone I in seven eyes, as zone II in three eyes and as zone III in three eyes.

The preoperative examination included visual acuity, intraocular pressure and B-scan ultrasonography. The follow-up examination included: visual acuity, intraocular pressure, and retinal attachment assessed with fundus examination after dilatation. The mean follow-up period was 13 months (range 10–20 months). Patients were examined on the next day after 1 week, after 1 month, 3 months, 6 months and year after operation.

Statistical computations were performed using GraphPad InStat software.

Surgical procedure

At the day of admission (within 6 h) a standard three-port immediate and complete 23G PPV (Constellation, Alcon, US) was performed under general or peribulbar anesthesia. In posttraumatic cases the corneal or scleral laceration was sutured, if it was not done in the region hospital.

Microbiological cultures were prepared from anterior chamber via paracentesis (Fig. 1) or using the vitrectomy cutter before switching on the irrigation. To obtain anterior-chamber samples 27G needle was inserted into the anterior chamber via limbus and 0.1 mL of fluid was aspirated to the tuberculin syringe. On the initiation of the PPV 0.2 mL of undiluted vitreous was aspirated into a syringe connected to the infusion line.
Fig. 1

Aspiration of the hypopyon for microbiological culture

After phacoemulsification with intraocular lens (IOL) implantation in phakic eyes was done, the anterior chamber maintainer was installed (Fig. 2) if there were difficulties with visualization of the infusion line into vitreous cavity. Next, the induction of posterior vitreous detachment (Fig. 3) as well as periphery shaving (Fig. 4) was performed. Intraocular Vancomycin (0.2 mg/ml) was administered at the time of PPV in the balanced salt solution (BSS) Plus (Alcon, Forth Worth, Texas, US) of the infusion line and irrigated continuously during the surgery. Vancomycin solution was prepared in the operation theatre by dissolving 1 g of Vancomycin in 10 ml of sterile normal (0.9 %) sialine and then dissolving 1 ml of this mixture in a sterile bottle of 500 ml of infusion fluid. The cost of one cruet containing 1 g of Vancomycin is about 2 euro. This cruet is bought by the hospital pharmacy in advance.
Fig. 2

Securing anterior chamber maintainer

Fig. 3

Posterior vitreous detachment during vitrectomy

Fig. 4

Shaving peripheral vitreous during vitrectomy

If aspirate was to be cultured, the material suctioned with the use of the instrument was collected in a sterile bottle. A positive culture was interpreted as either growth of the identical organism on two or more media or confluent growth on one medium at the inoculation site [10]. All patients received topical (moxifloxacin-every 1 h) and intravenous (cephazolin–2 x 1 g per day) broad-spectrum antibiotics to cover both Gram-positive and Gram-negative bacteria. This treatment was empirical and administered before the culture result was known.

Results

Study criteria were met by 45 patients: 30 with postoperative endophthalmitis and 15 with posttraumatic endophthalmitis (Tables 1 and 2). Median preoperative visual acuity in group with postoperative endophthalmitis was 3.0 logMAR, post PPV – 1.0 logMAR (p = 0.0001). Median preoperative visual acuity in group with posttraumatic endophthalmitis was 3.0 logMAR, post PPV – 1.3 logMAR (p = 0.0001). There were no sinificant differences between final visual acuities between groups (p < 0.05).
Table 1

Patient data, previous surgical procedures, surgical procedure in the treatment of endophthalmitis and results of visual acuity and result of microbiological culture regarding group of 30 patients with postoperative endophthalmitis

No

Gender,

age (years)

Previous surgical procedure

Surgical procedure, tamponade

Initial visual acuity

logMAR

Final visual acuity

logMAR

Result of microbiological culture

1

Male,

age 50–55

Phaco + IOL, trabeculectomy

PPV + BSS

3.0

2.0

Culture negative

2

Male,

age 70–75

Extracapsular cataract extraction, aphakia

PPV + silicone oil

3.0

2.0

Culture negativee

3

Male, age 80–85

Phaco + IOL,

PPV + silicone oil

3.0

1.0

Culture negative

4

Female, age 70–75

Phaco + IOL

PPV + silicone oil

3.0

3.0

Enterococcus fecalis

5

Female, age 80–85

Phaco + IOL

PPV + BSS

3.0

2.0

Culture negative

6

Male age 70–75

Avastin injection

Phaco + IOL+ PPV + BSS

1.3

1.3

Staphylococcus epidermidis

7

Male, age 55–60

Secondary IOL implantation

PPV + BSS

3.0

0.4

Staphylococcus epidermidis

8

Male, age 70–75

Phaco + IOL

PPV + BSS

3.0

1.0

Culture negative

9

Female, age 80–85

Phaco + IOL

PPV + BSS

3.0

1.0

Staphylococcus aureus

10

Female, age 70–75

Secondary IOL implantation

PPV + BSS

3.0

0.7

Culture negative

11

Male, age 50–55

Phaco + IOL + PPV + silicone oil

PPV + silicone oil removal + BSS

1.3

1.0

Staphylococcus epidermidis

12

Female, age 65–70

Ahmed valve implantation, Phaco + IOL

PPV + KPL + TKP + IOL explantation + silicone oil

3.0

3.0

Culture negative

13

Female, age 60–65

Phaco + IOL

PPV + BSS

3.0

1.0

Culture negative

14

Female, age 65–70

Phaco + IOL

PPV + silicone oil

3.0

1.0

Staphylococcus aureus

15

Female, age 80–85

Phaco + IOL

PPV + silicone oil

3.0

1.3

Staphylococcus aureus

16

Male, age 75–80

Avastin intravitreal injection

Paco + IOL + BSS

3.0

1.0

Culture negative

17

Male, age 80–85

Phaco + IOL

PPV + BSS

3.0

0.4

Culture negative

18

Male, age 70–75

Phaco + IOL

PPV + BSS

3.0

0.7

Staphylococcus epidermidis

19

Male, age 65–70

Avastin intravitreal injection

PPV + phaco + IOL + silicone oil

3.0

1.3

Staphylococcus epidemidis

20

Female, age 70–75

Phaco + IOL

PPV + silicone oil

0.7

0.5

Culture negative

21

Male, age 20–25

Phaco + IOL

PPV + silicone oil

2.4

0.4

Culture negative

22

Male, age 50–55

Phaco + IOL

PPV + silicone oil

3.0

1.0

Staphylococcus epidermidis

23

Female, age 70–75

Secondary IOL implantation

PPV + BSS

2.4

2.0

Culture negative

24

Female, age 60–65

Phaco + IOL

PPV + silicone oil

2.4

1.0

Culture negative

25

Female, age 70–73

Phaco + IOL

PPV + silicone oil

2.4

2.4

Enterococcus fecalis

26

Male, age 70–75

Phaco + IOL

PPV + BSS

2.4

0.7

Culture negative

27

Female, age 80–85

Phaco+ IOL

PPV + BSS

3.0

3.0

Streptococcus oralis

28

Female, age 80–85

Phaco + IOL

PPV + silicone oil

2.4

1.7

Culture negative

29

Female, age 55–60

Phaco + IOL

PPV + silicone oil

2.1

2.4

Bacillus cereus

30

Female, age 60–65

Phaco + IOL

TPPV + BSS

2.1

0.7

Culture negative

Abbreviations: Phaco phacoemulsification, PPV pars plana vitrectomy, BSS balanced salt solution, IOL intraocular lens, KPL keratoplasty, TKP temporary keratoprosthesis

Table 2

Patient data, type of injury, surgical procedure and results of visual acuity and result of microbiological culture examination regarding group of 15 patients with posttraumatic endophthalmitis

No

Gender, age

Type of injury, zone

Surgical procedure, tamponade

Initial visual acuity logMAR

Final visual acuity logMAR

Result of microbiological culture

1

Female, age 75–80

Pseudophakic, zone I

PPV + BSS

2.0

0.3

Staphylococcus aureus

2

Male, age 45–50

IOFB, traumatic cataract, zone I

PPV + phaco + IOL + silicone oil

3.0

2.4

Culture negative

3

Male, age 25–30

IOFB, traumatic cataract zone I

PPV + phaco + IOL + silicone oil

3.0

2.0

Culture negative

4

Male, age 55–60

Pseudophakic, zone III

PPV + BSS

3.0

0.4

Staphylococcus aureus

5

Male, age 45–50

Pseudophakic, zone I

PPV + BSS

2.0

1.3

Culture negative

6

Male, age 55–60

Traumatic cataract, zone III

PPV + phaco + IOL+ silicone oil

3.0

1.3

Culture negative

7

Female, age 35–40

Traumatic cataract, zone I

Phaco + IOL + KPL + PPV + silicone oil

3.0

3.0

Bacillus cereus

8

Male, age 40–45

IOFB, traumatic cataract, zone I

PPV+ phaco + IOL+ silicone oil

2.0

2.0

Culture negative

9

Male, age 20–25

Traumatic cataract, retinal detachment, vitrous haemorrhage, IOFB, zone II

PPV+ phaco + IOL+ silicone oil

3.0

3.0

Bacillus cereus

10

Male, age 30–35

Traumatic cataract, zone III

PPV + phaco + IOL++silicone oil

3.0

0.7

Culture negative

11

Male, age 60–65

Traumatic cataract, IOFB, zone II

PPV + phaco + IOL + silicone oil

3.0

2.0

Staphylococcus aureus

12

Male, age 55–60

Traumatic cataract, retinal detachment, IOFB, zone II

PPV+ phaco + IOL+ silicone oil

3.0

2.0

Staphylococcus epidermidis

13

Male, age 30–40

IOFB, traumatic cataract

PPV+ phaco + IOL + BSS

3.0

0.5

Culture negative

14

Male, age 20–30

Traumatic cataract, zone I

PPV+ phaco + IOL silicone oil

3.0

1.0

Staphylococcus epidermidis

15

Male, age 30–40

IOFB, traumatic cataract

PPV+ phaco + IOL SF6 gas

3.0

0.5

Culture negative

Abbreviations: Phaco phacoemulsification, PPV pars plana vitrectomy, BSS balanced salt solution, IOL intraocular lens, IOFB intraocular foreign body, TKP temporary keratoprosthesis

Overall, after PPV the visual acuities were improved in 38 cases (84 %) – 12 posttraumatic and 26 postoperative, stable in seven cases (16 %) cases - 3 posttraumatic and four postoperative.

Mean intraocular pressure was 14 mmHg (range 7–18 mmHg) before treatment and 19 mmHg (range 15–24 mmHg) after follow-up period.

In 12 cases PPV was combined with traumatic cataract removal with IOL implantation. Eyes after Avastin injections were phakic and PPV was combined with phacoemulsification and IOL implantation, in one case PPV was combined with IOL explantation. Retinal detachment was present in two cases of posttraumatic eyes, IOFB was present in eight cases. The mean time from the injury to wound repair was 2 days (1–4 days).

As a tamponade, BBS (20 cases - 4 posttraumatic and 16 postoperative) or 5000 sct silicone oil (25 cases–10 posttraumatic and 19 postoperative) or SF6 gas (one posttraumatic case) was used. PPV was combined with temporary keratoprosthesis (TKP) and keratoplasty in two patients (one posttraumatic and one postoperative).

Positive culture from either anterior chamber paracentesis or vitreous tapping or both were found in seven cases of posttraumatic eyes (47 %) of 15 patients (5 - Staphylococcus epidermidis; 2 - Bacillus cereus) and in 13 (43 %) cases of postoperative endophthalmitis (6 - Staphylococcus epidermidis, 3 - Staphylococcus aureus, 2 - Enterococcus fecalis, 1 - Bacillus cereus 1 - Streptococcus oralis). In 17 postoperative and eight posttraumatic cases culture was negative.

In the follow-up period of 1 year no retinal detachment was observed. Silicone oil was removed after mean period of 1 year and all retinas were attached. One from the operated cases, which underwent PPV combined with TKP and penetrating keratoplasty due to postoperative endophthalmitis following Ahmed valve implantation, ended in the phthisis bulbi. No eye was enucleated, no eye revealed signs of sympathetic ophthalmia.

Discussion

In the present study we retrospectively evaluated data of patients with endophthalmitis following intraocular surgery and open globe eye trauma treated with immediate 23G PPV with Vancomycin dissolved in the infusion fluid.

The Endophthalmitis Vitrectomy Study (EVS) – the major randomized trial in this subject - published in 1995 recommended intravitreal antibiotics if the visual acuity is greater than hand motion and PPV if visual acuity is equal to light perception [11]. EVS was designed to compare vitreous tapping with vitrectomy only in the treatment of postoperative endophthalmitis following cataract surgery and secondary IOL implantation. In this study there was no difference between final visual acuities with and without the use of systemic antibiotics. In EVS study 100 % of Gram-postive bacteria were susceptible to Vancomycin.EVS study showed that immediate (defined by EVS as within 6 h from the presentation) PPV has satisfactory results and quicker recovery of vision in the management of this severe ocular infection only in eyes presented with light perception. However, many of the patients treated with vitreous tapping in fact underwent a mechanical vitrectomy, which is also called a vitreous biopsy. In effect, many of these patients underwent a vitrectomy, but it was a subtotal procedure (about 50 % of the vitreous) without induction of posterior vitreous detachment.

In our study all the patients underwent a “complete” PPV with Vancomycin dissolved in the infusion fluid and there was significant improvement of the visual acuity both in postoperative and posttraumatic endophthalmitis. As it was advocated by Kuhn and co-workers, withdrawal of the vitreous body during PPV removes the bulk of infectious organisms and associated inflammatory debris load in the vitreous cavity and provides a large quantity of specimen for diagnostic smear and culture, and enables better antibiotics distribution [12]. Moreover, PPV reduces the incidence and severity of retinal, especially macular, complications and thus achieves a higher possibility of favorable visual outcome. Early PPV seems to be much more preferred in posttraumatic endophthalmitis, as more profound inflammation is observed and there is increased probability of more virulent organisms.

The surgical technique of PPV in endophthalmitis is similar to a standard PPV with some exceptions. Securing the infusion cannula correctly may be difficult due to purulent vitreous body and hazy cornea. A longer infusion cannula (6 mm) or anterior chamber maintainer may be useful. If here is oedema of the corneal epithelium, its scraping may be necessary to obtain good visibility of the retina and vitreous. In most of the cases removal of the hypopyon and fibrous membranes form the anterior chamber using 23G forceps is necessary. Peripheral shaving should be performed with care to avid iatrogenic breaks of the retina, as adherent vitreous and fragile retina may be more prone to developing retinal breaks and detachments. Posterior vitreous detachment was induced in all cases. Many surgeons give Vancomycin intravitreally at the end of the surgery, however, in our opinion, applying Vancomycin instantly during PPV in the infusion line gives the highest concentration “at the target site” and seems to be better for the circulation of the antibiotic in the eye during surgery (about 1 h). Intravitreal administration of Vancomycin lasts for the limited time period only, there is a risk of iatrogenic damage – cataract and retinal breaks. Moreover, the margin for error between chemotherapy and retinal toxicity is very narrow.

Vancomycin is effective against most Gram-positive bacteria, also methycillin-resistant, including Staphylococcus, Streptococcus and Bacillus species. Vancomycin is a glycopeptide antibiotic inhibiting bacterial cell wall protein synthesis by binding to the 30S rRNA molecule of the bacterial ribosome. Resistant mutants are very rare. Vancomycin seems to be well tolerated by ocular structures, it is cleared from the eye anteriorly, resulting in a long half-life. There is also no evidence of retinal toxicity. Data from rabbit studies demonstrated a vitreal half-life of 20–40 h in uninfected rabbit eyes and 38–54 h in infected rabbit eyes [13].

It has been shown that intravenous Vancomycin does not reach therapeutic concentrations in vitreous due to the protective effect of the blood-ocular fluid barrier [14]. However, intraocular inflammation increases the permeability of the blood-ocular fluid barrier, enhancing penetration of systemic antibiotics into the vitreous cavity [14].

There are no strict indications for intravitreal Vancomycin injection as the primary treatment. It depends on the individual decision made by the surgeon. In our opinion it should be reserved for endophthalmitis cases with visible red reflex and visual acuity better than 0.1.

In a rabbit model of endophthalmitis caused by intravitreal injection of Bacillus cereus, it has been demonstrated that eyes treated with combined PPV and intraocular Vancomycin during the early stage of infection resulted in significantly greater retinal function compared with that of intraocular antibiotics alone [15].

There are reports that Vancomycin in some countries, especially in Europe, is used intracamerally or in the irrigating solution during cataract surgery as a prophylaxis of endophthalmitis [16, 17]. However, it may increase the risk of Vancomycin-resistant bacteria growth, thus Vancomycin should not be used for prohylaxis of endophthalmitis.

Direct intracameral injection of cefuroxime (1 mg) given at the end of the surgery is recommended by the ESCRS guidelines as a standard prophylactic intervention significantly reducing the postoperative infections rate [2]. In our hospital we use intracameral cefuroxime routinely in all patients at the end of cataract surgery, without exceptions, but we are not confident if it is the same in all regional hospitals in Poland. In a recent national Survey in Europe it was investigated the role of intracameral cefuroxime in the prevention of endophthalmitis following cataract surgery [18]. An incidence of endophthalmitis greater than 0.13 % was encountered significantly more frequently among centers that did not employ intracameral cefuroxime. However, we need to have updated data and try to choose the antibiotics based on the local microbiological surveillance [18]. Preoperative application of povidone - iodine to skin and conjunctiva seems to be proven intraoperative endophthalmitis prophylaxis [19]. This is the best surgical preparation technique. The systemic antibiotics decrease the bacteria loading to the eye in endophthalmitis. In our group of patients we used intravenous cephazolin - a first generation cephalosporin antibiotic. Topical antibiotic used in this study was fluorochinolon – moxifloxacin. It has been shown that fuorchinolones penetrate into the inflamed and non-inflammed vitreous better than other classes of antibiotics [20]. However, in the light of “choosing wisely” philosophy we should not probably use fluorquinolones preoperatively, but we also think that in the real world medical legal issues may predominate in our decisions [21]. Large studies have shown that there are several changes in bacteria composition of the conjunctiva over time [22, 23, 24]. Moreover, our concerns are about the increased resistance of Gram + germs to fluorquinolones. From the other side, it was proven that postoperative usage of fluorquinolones reduces the risk of endophthalmtis [25].

It is difficult to compare our results with other studies, as there is no standardized approach to the management of posttraumatic endophthalmitis. Microincision vitrectomy surgery, including 23- and 25-gauge PPV, is often described as being minimally invasive.

In our study most of the cases were treated with 23G PPV and silicone oil as a tamponade, as it does not support microbial growth [26]. Moreover, in an in vitro study, silicone oil was effective in the suppression of multiple endophthalmitis causing organisms [27]. The technological advances of small-gauge PPV seem to afford visual benefit, with more rapid healing, less discomfort, and an acceptably low incidence of adverse events compared with those observed in conventional 20-gauge PPV [28]. A discussion still exists concerning the appropriate timing for PPV in traumatized eyes. However, most reports agree that PPV should be performed without delay in severe cases of endophthalmitis, especially those involving IOFB [6].

In the present study there were no significant differences in final visual acuity between eyes with postoperative and posttraumatic endophthalmitis. However, it has already been shown, that there are different factors responsible for worse than postoperative endophthalmitis visual prognosis: virulence of the infectious organism, the severity of associated trauma, the rapidity of diagnosis and institution of therapy [29], as well as poor presenting visual acuity, inability to visualize the optic disc on indirect ophthalmoscopy, presence of vitreous membranes on ultrasonography, trauma by a needle and a culture-positive vitreous biopsy [3].

In our study the positive cultures were found in 44 % of cases. In the literature the rate of positive cultures is similar: 40 % in study of 97 patients by Vedantham [30], 44 % in the study of 955 samples analyzed by Ramakrishnan and co-operators [31] and 58 % in the study of 62 patients conducted by Das [32].

There has been wide variety of pathogens found in the studies dealing with posttraumatic and postoperative endophthalmitis [32]. Coagulase-negative Staphylococcus remains the most frequently identified cause of endophthalmitis [33]. Bacillus cereus is ranked second behind Staphylococci in the prevalence of posttraumatic endophthalmitis and some cases are polymicrobal. In our study Staphylococcus epidermidis, Bacillus cereus, Enterococcus fecalis and Streptococcus oralis were found in microbiological examination in half of cases. The low rate of culture positivity in this study could be due to poor sampling technique, the use of antibiotics postoperatively or simply sterile endophthalmitis. It has been already reported that cases with negative cultures at presentation were more likely to have improvement in visual acuity compared with culture-positive cases [34]. Ramakrishnan and colleagues [31] reported in 10-years retrospective study that the intraocular specimen may remain culture-negative despite obvious signs of infection in certain cases of posttraumatic endophthalmitis.

In the setting of an IOFB or soil contamination there is a high incidence of Bacillus species endophthalmitis [6]. Endophthalmitis caused by Bacillus cereus is characterized by a rapid onset of severe pain, inflammation and progression to panophthalmitis. The current antibiotic treatment for acute-onset bacterial endophthalmitis includes Vancomycin for gram-positive coverage and either ceftazidime or an aminoglycoside for gram-negative coverage [35].

The incidence of posttraumatic endophthalmitis may be decreased by early wound closure and prompt initiation of antibiotics. Prophylactic factors in the setting of trauma include primary wound repair within 24 h, lack of tissue prolapse into wounds and self-sealing wounds [36]. Systemic broad-spectrum antibiotic therapy is a common approach to prophylaxis against endophthalmitis in the setting of open-globe injury [37].

Conclusions

We believe that Vancomycin is still an excellent antibiotic for the empirical treatment of bacterial endophthalmitis. Antibiotic choice in preventing endophthalmitis after ophthalmic surgery should be based on knowing the organisms causing endophthalmitis in that region, along with their antibiotic susceptibilities. In every tertiary vitreoretinal center, clear treatment guidelines should be established, all necessary antibiotics and an examination of the microbiological specimens should be available at all times.

The results of this retrospective study support the use of early PPV combined with Vancomycin in infusion in cases of both postoperative and posttraumatic infectious endophthalmitis. With this strategy the final visual outcome may be markedly improved.

Notes

Funding

No funding was obtained for this study.

Availability of data and materials

All the data are available upon request.

Authors’ contributions

RR - substantial contribution to conception and design of the study, analysis and interpretation of data, drafting the manuscript, KN - analysis and interpretation of the data, drafting the manuscript, TC, AK – acquisition and substantial analysis of the data, MK, PK, JMW – drafting the manuscript and revising it critically for important intellectual content, AJ, RM - substantial contribution to analysis and interpretation of the data. All authors read and approved the final manuscript.

Competing interests

The authors declare that they have no competing interests.

Consent for publication

Written consent to publish the information contained in the manuscript and tables was obtained from all participants.

Ethics approval and consent to participate

The study was approved by the local Ethic Committee at the University in Lublin, Poland. The patients gave their written informed consent to participate in the study and publish the data.

References

  1. 1.
    Callegan MC, Engelbert M, Parke 2nd DW, et al. Bacterial endophthalmitis: epidemiology, therapeutics, and bacterium-host interactions. Clin Microbiol Rev. 2002;15(1):111–24.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    ESCRS Guidelines on prevention, investigation and management of post-operative endophthalmitis. Editors Peter Barry, Wolfgang Behrens-Baumann, Uwe Pleyer & David Seal. The European Society for Cataract & Refractive Surgeons, Version 2 August 2007.Google Scholar
  3. 3.
    Das T, Kunimoto DY, Sharma S, Jalali S, Majji AB, Nagaraja Rao T, Gopinathan U, Athmanathan S, Endophthalmitis Research Group. Relationship between clinical presentation and visual outcome in postoperative and posttraumatic endophthalmitis in south central India. Indian J Ophthalmol. 2000;48:123–8.Google Scholar
  4. 4.
    Essex RW, Yi Q, Charles PG, Allen PJ. Post-traumatic endophthalmitis. Ophthalmology. 2004;111(11):2015–22.CrossRefPubMedGoogle Scholar
  5. 5.
    Boldt HC, Pulido JS, Blodi CF, Folk JC, Weingeist TA. Rural endophthalmitis. Ophthalmology. 1989;96(12):1722–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Thompson JT, Parver LM, Enger CL, Mieler WF, Liggett PE. Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies. Ophthalmology. 1993;100(10):1468–1474.7.CrossRefPubMedGoogle Scholar
  7. 7.
    Al-Mezaine HS, Osman EA, Kangave D. Risk factors for culture-positive endophthalmitis after repair of open globe injuries. Eur J Ophthalmol. 2010;20(1):201–8.PubMedGoogle Scholar
  8. 8.
    Kresloff MS, Castellarin AA, Zarbin MA. Endophthalmitis. Surv Ophthalmol. 1998;43(3):193–224.CrossRefPubMedGoogle Scholar
  9. 9.
    Kuhn F, Morris R, Witherspoon CD, Heimann K, Jeffers JB, Treister G. A standardized classification of ocular trauma. Ophthalmology. 1996;103:240–3.CrossRefPubMedGoogle Scholar
  10. 10.
    Maguire JI. Postoperative endophthalmitis: optimal management and the role and timing of vitrectomy surgery. Eye. 2008;22(10):1290–300.CrossRefPubMedGoogle Scholar
  11. 11.
    Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 1995; 113(12): 1479–1496.Google Scholar
  12. 12.
    Kuhn F, Gini G. Ten years after… are findings of the endophthalmitis vitrectomy study still relevant today? Graefes Arch Clin Exp Ophthalmol. 2005;243:1197–9.CrossRefPubMedGoogle Scholar
  13. 13.
    Smith MA, Sorensen JA, Lowy FD, et al. Treatment of experimental methicillin resistant staphylococcus epidermidis endophthalmitis with intravitreal vancomycin. Ophthalmology. 1986;93:1328–35.CrossRefPubMedGoogle Scholar
  14. 14.
    Ferencz JR, Assia EI, Diamantstein L, Rubinstein E. Vancomycin concentration in the vitreous after intravenous and intravitreal administration for postoperative endophthalmitis. Arch Ophthalmol. 1999;117(8):1023–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Callegan MC, Guess S, Wheatley NR, Woods DC, Griffin G, Wiskur BJ, Leonard R. Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitis. Retina. 2011;31(8):1518–1524.15.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Anijeet DR, Palimar P, Peckar CO. Intracameral vancomycin following cataract surgery: an eleven-year study. Clin Ophthalmol. 2010;26:321–6.CrossRefGoogle Scholar
  17. 17.
    Sobaci G, Tuncer K, Taş A, Ozyurt M, Bayer A, Kutlu U. The effect of intraoperative antibiotics in irrigating solutions on aqueous humor contamination and endophthalmitis after phacoemulsification surgery. Eur J Ophthalmol. 2003;13:773–8.PubMedGoogle Scholar
  18. 18.
    Grosso A, Pertile G, Marchini G, Scarpa G, Ceruti P, Prigione G, Romano MR, Bert F, Gili R, Panico C, Siliquini R, Engelbert M. Adherence to European society for cataract and refractive surgery recommendations among Italian cataract surgeons: a survey. Eur J Ophthalmol. 2016;8.Google Scholar
  19. 19.
    Apt L, Isenberg S, Yorhimori R. Chemical preparation of the eye in ophthalmic surgery: the effect of povidone-iodine on the conjunctiva. Arch Ophthalmol. 1984;102:728–9.CrossRefPubMedGoogle Scholar
  20. 20.
    Fiscella RG, Nguyen TK, Cwik MJ, et al. Aqueous and vitreous penetration of levofloxacin after oral administration. Ophthalmology. 1999;106:2286–90.CrossRefPubMedGoogle Scholar
  21. 21.
    Parke 2nd DW, Coleman AL, Rich 3rd WL, et al. Choosing wisely: five ideas that physicians and patients can discuss. Ophthalmology. 2013;120:443–4.CrossRefPubMedGoogle Scholar
  22. 22.
    Hsu J, Gerstenblith AT, Garg SJ, et al. Conjunctival flora antibiotic resistance patterns after serial intravitreal injections without postinjection topical antibiotics. Am J Ophthalmol. 2014;157:3514–518.CrossRefGoogle Scholar
  23. 23.
    Dave SB, Toma HS, Kim SJ. Changes in ocular flora in eyes exposed to ophthalmic antibiotics. Ophthalmology. 2013;120:937–41.CrossRefPubMedGoogle Scholar
  24. 24.
    Gower EW1, Lindsley K, Nanji AA, et al. Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. Cochrane Database Syst Rev. 2013;7:CD006364.Google Scholar
  25. 25.
    Rudnisky CJ, Wan D, Weis E. Antibiotic choice for the prophylaxis of post-cataract extraction endophthalmitis. Ophthalmology. 2014;121:835–41.CrossRefPubMedGoogle Scholar
  26. 26.
    Azad R, Ravi K, Talwar D, Rajpal Kumar N. Pars plana vitrectomy with or without silicone oil endotamponade in post-traumatic endophthalmitis. Graefes Arch Clin Exp Ophthalmol. 2003;241(6):478–83.CrossRefPubMedGoogle Scholar
  27. 27.
    Ozdamar A, Aras C, Ozturk R, Akin E, Karacorlu M, Ercikan C. In vitro antimicrobial activity of silicone oil against endophthalmitis-causing agents. Retina. 1999;19(2):122–126.20.CrossRefPubMedGoogle Scholar
  28. 28.
    Recchia FM, Scott IU, Brown GC, Brown MM, Ho AC, Ip MS. Small-gauge pars Plana vitrectomy: a report by the American academy of ophthalmology. Ophthalmology. 2010;117(9):1851–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Brinton GS, Topping TM, Hyndiuk RA, Aaberg TM, Reeser FH, Abrams GW. Posttraumatic endophthalmitis. Arch Ophthalmol. 1984;102(4):547–50.22.CrossRefPubMedGoogle Scholar
  30. 30.
    Vedantham V, Nirmalan PK, Ramasamy K, Prakash K, Namperumalsamy P. Clinico-microbiological profile and visual outcomes of post-traumatic endophthalmitis at a tertiary eye care center in South India. Indian J Ophthalmol. 2006;54(1):5–10.CrossRefPubMedGoogle Scholar
  31. 31.
    Ramakrishnan R, Bharathi MJ, Shivkumar C, Mittal S, Meenakshi R, Khadeer MA, Avasthi A. Microbiological profile of culture-proven cases of exogenous and endogenous endophthalmitis: a 10-year retrospective study. Eye. 2009;23:945–56.CrossRefPubMedGoogle Scholar
  32. 32.
    Das T, Hussain A, Naduvilath T, Sharma S, Jalali S, Majji AB. Case control analyses of acute endophthalmitis after cataract surgery in South India associated with technique, patient care, and socioeconomic status. J Ophthalmol. 2012;2012:298459.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Gentile RC, Shukla S, Shah M, et al. Microbiological spectrum and antibiotic sensitivity in endophthalmitis: a 25-year review. Ophthalmology. 2014;121:1634–42.CrossRefPubMedGoogle Scholar
  34. 34.
    Nobe JR, Gomez DS, Liggett P, Smith RE, Robin JB. Post-traumatic and postoperative endophthalmitis: a comparison of visual outcomes. Br J Ophthalmol. 1987;71(8):614–7.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Roth DB, Flynn HW. Antibiotic selection in the treatment of endophthalmitis: the significance of drug combinations and synergy. Surv Ophthalmol. 1997;41:395–40.CrossRefPubMedGoogle Scholar
  36. 36.
    Ahmed Y, Schimel AM, Pathengay A, Colyer MH, Flynn HW. Endophthalmitis following openglobe injuries. Eye. 2012;26:212–7.CrossRefPubMedGoogle Scholar
  37. 37.
    Bhagat N, Nagori S, Zarbin M. Post-traumatic infectious endophthalmitis. Surv Ophthalmol. 2011;56(3):214–5.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s). 2016

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Robert Rejdak
    • 1
    • 2
  • Tomasz Choragiewicz
    • 1
    • 3
  • Agnieszka Kalinowska
    • 1
  • Michael J. Koss
    • 4
  • Piotr Ksiazek
    • 5
  • Joanna Moneta-Wielgos
    • 1
  • Ryszard Maciejewski
    • 6
  • Anselm G. Jünemann
    • 7
  • Katarzyna Nowomiejska
    • 1
  1. 1.Department of General OphthalmologyMedical University of LublinLublinPoland
  2. 2.Department of Experimental PharmacologyMedical Research Centre, Polish Academy of SciencesWarsawPoland
  3. 3.Department of Didactics and Medical SimulationHuman Anatomy Chair, Medical University of LublinLublinPoland
  4. 4.Department of OphthalmologyUniversity of HeidelbergHeidelbergGermany
  5. 5.Department of Public HealthMedical University of LublinLublinPoland
  6. 6.Human Anatomy DepartmentMedical University of LublinLublinPoland
  7. 7.Department of OphthalmologyUniversity of RostockRostockGermany

Personalised recommendations